AI & ChatGPT searches , social queriess for CTEP
Search references for CTEP. Phrases containing CTEP
See searches and references containing CTEP!
Search references for CTEP. Phrases containing CTEP
See searches and references containing CTEP!CTEP
Chemical compound
CTEP (Ro4956371) is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor
CTEP
US certifying body
chartered portfolio manager (CPM), chartered trust and estate planner (CTEP), chartered wealth manager (CWM), and master financial professional (MFP)
American Academy of Financial Management
American_Academy_of_Financial_Management
Argentine lawyer and politician (born 1983)
("Excluded Workers Movement"; MTE), the Confederation of Popular Economy Workers (CTEP, now known as UTEP), and the Patria Grande Front. Since 2025 he has sat in
Juan_Grabois
Amino acid
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Glutamine
Blue dye also used as a medication
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Methylene_blue
Type of white blood cell
use". Clinical Techniques in Equine Practice. 3 (2): 148–163. doi:10.1053/j.ctep.2004.08.006. Souppouris A (23 May 2013). "Scientists identify cell that could
Macrophage
Medication used to treat ADHD
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Atomoxetine
Series of events that restore integrity to damaged tissue after an injury
repair". Clinical Techniques in Equine Practice. 3 (2): 110–122. doi:10.1053/j.ctep.2004.08.009. de la Torre J, Sholar A (2006). "Wound healing: Chronic wounds"
Wound_healing
Condition in horses in which the esophagus is blocked
Clinical Techniques in Equine Practice. 4 (2). Elsevier: 117–119. doi:10.1053/j.ctep.2005.04.002. Ferraro, GL; Wilson WD; Basile T; Meierhenry BJ (April 2006)
Choke_(horse)
Antibiotic medication
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Minocycline
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Pomaglumetad_methionil
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Eglumetad
Ubiquitous antioxidant compound in living organisms
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Glutathione
Chemical in plants
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Apigenin
Colorless gas with the formula NO
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Nitric_oxide
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
2F-NENDCK
American medical oncologist specializing in breast cancer
Therapy Evaluation Program (CTEP) subsequently announced that the updated eligibility criteria were mandatory for use in all CTEP-sponsored clinical trials
Tatiana_Prowell
Chemical compound
alkylating agent therapy. Epirubicin's toxicity is according to the NCI-CTEP Common Toxicity Criteria, version 2.0. In some studies, patient toxicity
Epirubicin
Spice made from crocus flowers
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Saffron
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
LY-341495
Horse disease
patient", Clinical Techniques in Equine Practice, 3 (2): 225–236, doi:10.1053/j.ctep.2004.08.007 "Constable SA, Equine Lymphangitis, 2010". Archived from the
Equine_lymphangitis
Medication used to treat overdose of paracetamol
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Acetylcysteine
American clinical trials group
0b013e3181ff7e23. PMC 3135766. PMID 21326081. "Cancer Therapy Evaluation Program (CTEP) Major Initiatives". National Cancer Institute. NCI Cancer Therapy Evaluation
Children's_Oncology_Group
Pharmaceutical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
2-FXPr
Argentine politician
National Deputy for Buenos Aires. Additionally, Fagioli is also involved in the CTEP-UTEP, the informal sector workers' union. Fagioli was born on 27 March 1991
Federico_Fagioli
Service of the National Cancer Institute
Clinical Oncology. 28 (15s): 6077. doi:10.1200/jco.2010.28.15_suppl.6077. "CTEP". "NCI's Cancer Trials Support Unit (CTSU) | Westat". CTSU Website NCI National
Cancer_Trials_Support_Unit
Amino acid and neurotransmitter
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Glutamic_acid
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Fenobam
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Cytidine
Virus subtype
Retrieved 10 April 2023. Equine influenza virus by Wilson et al doi:10.1053/j.ctep.2006.03.013 Sharp, GB; Kawaoka, Y; Jones, DJ; et al. (August 1997). "Coinfection
Influenza A virus subtype H3N8
Influenza_A_virus_subtype_H3N8
Molecule used to overcome antibiotic resistance in bacteria
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Clavulanic_acid
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
NMDA_receptor_modulator
Volatile or gaseous anesthetic compound delivered by inhalation
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Inhalational_anesthetic
Rare complication of equine strangles
2006). "Streptococcus equi subsp. equi (Strangles) Infection". Clinical Techniques in Equine Practice. 5 (3): 211–217. doi:10.1053/j.ctep.2006.03.016.
Purpura_haemorrhagica
Naturally occurring glutamate receptor agonist neurotoxin
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Ibotenic_acid
injuries". Clinical Techniques in Equine Practice. 3 (4): 312–322. doi:10.1053/j.ctep.2004.04.003. Stover, S. M., Murray, A. (2008). "The California Postmortem
Susan_Stover
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
HYDIA
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
MMPIP
Neurological and psychiatric drug
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Deudextromethorphan/quinidine
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Agmatine
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
DMeOB
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
MGS-0039
Combination drug
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Estradiol valerate/prasterone enanthate
Estradiol_valerate/prasterone_enanthate
Genetic disease in horses
Horses". Clinical Techniques in Equine Practice. 4 (4): 314–323. doi:10.1053/j.ctep.2005.10.006. Fanelli, H.H. (2005). "Coat Color Dilution Lethal ("lavender
Lavender_foal_syndrome
Metabotropic glutamate receptor 5 positive allosteric modulator
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
LSN2463359
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
BAY_36-7620
Class of pharmaceutical compounds
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Excitatory amino acid receptor agonist
Excitatory_amino_acid_receptor_agonist
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
ACPD
Pharmaceutical drug
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Dextromethorphan/quinidine
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Basimglurant
Combination drug
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Ketofol
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
S-Nitrosoglutathione
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
2-Methyl-6-(phenylethynyl)pyridine
2-Methyl-6-(phenylethynyl)pyridine
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Kainic_acid
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Dihydroxyphenylglycine
Subcategory of ether used in anesthesiology
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Halogenated_ether
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Xanthurenic_acid
Medication used to treat amyotrophic lateral sclerosis
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Riluzole
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Ro67-4853
Type of glutamate receptor
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Metabotropic glutamate receptor
Metabotropic_glutamate_receptor
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
MTEP
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
LY-379,268
Medical usage of the prasterone compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Prasterone
University courses in Nunavut, Canada
experiences through exchanges. The Community Teacher Education Program (CTEP) provides teacher training, following the NTEP curriculum, at the community
Nunavut Teacher Education Program
Nunavut_Teacher_Education_Program
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
L-AP4
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
CPCCOEt
Early anesthetic
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
ACE_mixture
Neuron membrane protein
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Glutamate_receptor
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Glutathione_disulfide
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Glufimet
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
ADX-71149
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Hypericin
Derivative of aspartic acid found in the brain
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
N-Acetylaspartic_acid
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
SIB-1893
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
RO4491533
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
EGLU
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Mavoglurant
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Philanthotoxin
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
PHCCC
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Nortilidine
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Pomaglumetad
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Foliglurax
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Remeglurant
Mammalian protein found in humans
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Metabotropic glutamate receptor 2
Metabotropic_glutamate_receptor_2
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
LY-307,452
Antialcohol treatment
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
GET-73
Chemical
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
DCPG
Medication
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
AZD9272
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
DCG-IV
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
LY-487,379
Antidepressant and cerebral activator
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Indeloxazine
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Pregnenolone_succinate
Class of chemical compounds
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Excitatory amino acid receptor antagonist
Excitatory_amino_acid_receptor_antagonist
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Aceglutamide
Mammalian protein found in humans
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Metabotropic glutamate receptor 5
Metabotropic_glutamate_receptor_5
Mammalian protein found in humans
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Metabotropic glutamate receptor 6
Metabotropic_glutamate_receptor_6
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Decoglurant
Chemical compound
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Quisqualic_acid
Medication
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Prasterone_sulfate
Affecting glutamate systems in the brain
Quisqualic acid VU-1545; Positive allosteric modulators: LSN2463359 Antagonists: CTEP DMeOB LY-344,545 Mavoglurant MCPG NPS-2390 Remeglurant SIB-1757 SIB-1893;
Glutamatergic
CTEP
CTEP
CTEP
CTEP
Girl/Female
Hindu, Indian, Traditional
Acting According to Dharma
Male
Dutch
, father of a multitude.
Girl/Female
German, Greek, Latin
Little Flower
Girl/Female
Tamil
God
Boy/Male
Tamil
Taraprashad | தாரா பà¯à®°à®·à®¾à®¤
Star
Boy/Male
Tamil
Padmayani | பதà¯à®®à®¾à®¯à®¾à®¨à¯€
Lord Brahma, Buddha
Boy/Male
Hindu, Indian, Sanskrit
Who has Strength of an Elephant
Male
Italian
Pet form of Italian Pasquale, PASQUALINO means "Passover; Easter."
Girl/Female
Muslim
Honey comb
Boy/Male
Indian
Shining, Bright, Name of the Sun
CTEP
CTEP
CTEP
CTEP
CTEP